ScholarWorks@Korea University College of Medicine: Hong, Soon Jun

Detailed Information

Hong, Soon Jun (홍순준)

Anam Hospital (Department of Cardiology, Anam Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

percutaneous coronary intervention:14||hypertension:11||myocardial infarction:9||amlodipine:8||drugeluting stent:7||rosuvastatin:7||hypercholesterolemia:7||ezetimibe:6||drugeluting stents:6||Diabetes mellitus:6||Myocardial infarction:6||telmisartan:6||acute myocardial infarction:5||coronary artery disease:5||Percutaneous coronary intervention:5||Acute coronary syndrome:4||combination therapy:4||losartan:4||restenosis:4||Drugeluting stents:4||clinical outcome:4||chlorthalidone:3||Endothelial progenitor cell:3||adiponectin:3||diabetes:3||diabetes mellitus:3||Neointima:3||drugeluting stent(s):3||Ezetimibe:3||Atherosclerosis:3||blood pressure:3||talin:3||central blood pressure:3||Pioglitazone:3||major adverse cardiac event:3||Hypercholesterolemia:3||Angioplasty:2||LDLC:2||singepill combination:2||arterial stiffness:2||allcause mortality:2||ST elevation myocardial infarction:2||atorvastatin:2||atrial fibrillation:2||Acute myocardial infarction:2||hydrochlorothiazide:2||Focal adhesion:2||adiposederived stem cells:2||stent thrombosis:2||NTproBNP:2||hypertriglyceridemia:2||Bifurcation:2||bifurcation:2||black raspberry:2||coronary bifurcation lesion:2||Left main disease:2||Coronary disease:2||inflammation:2||Combination therapy:2||Left ventricle:2||Slow release:2||Aortic stiffness:2||Lipids:2||Drugeluting stent:2||acute coronary syndrome:2||Stem cell:2||intravascular ultrasound:2||Clopidogrel:2||Atorvastatin:2||Stents:2||Strain:2||nonHDLC:2||triple combination:2||left ventricular hypertrophy:2||Angiogenesis:2||Angiotensin receptor blockers:2||Pitavastatin:2||coronary flow reserve:2||lowdensity lipoprotein cholesterol:2||lowdose:2||Clinical efficacy:2||Atrial fibrillation:2||Instent restenosis:2||Heart failure with reduced ejection fraction:2||Coronary artery disease:2||Aortic valve stenosis:2||metabolic syndrome:2||Metabolic syndrome:2||Coronary artery stenosis:2||Pulse wave velocity:2||Coronary restenosis:2||combination:2||Carvedilol:2||dyslipidemia:2||Rosuvastatin:2||secondgeneration drugeluting stent:2||elderly:2||Korea:2||Optical coherence tomography:2||Hindlimb ischemia:1||Human endothelial colonyforming cells:1||Hypereosinophilic syndrome, myocardiris:1||Hypertension:1||Hypertension.:1||Hypertrophy:1||Immediate release:1||Immunosensing performances:1||Inflammation:1||Inflammatory markers:1||Integrated backscatter:1||Intravascular ultrasonography:1||Irbesartan:1||Ischemic hindlimb:1||KCH1521:1||LDL:1||LVH:1||Lateloss:1||Left main:1||Left ventricular systolic dysfunction:1||MCP1:1||MICROARRAY PLATFORMS:1||Macrophages:1||Major adverse cardiac event:1||Major adverse cardiovascular events:1||Major adverse event:1||Menopause:1||MicroRNA:1||MicroRNAs:1||Microfluidic system:1||Mitral valve insufficiency:1||Mortality:1||Multidetector Computed Tomography:1||Myocardium:1||Myocytes, cardiac:1||N:1||NEURONAL DIFFERENTIATION:1||NGAL:1||NSTEACS:1||NSTEMI:1||Neointima formation:1||Neointimal hyperplasia:1||Neovascularization:1||Newonset diabetes:1||Oral contraceptives:1||Ouabain:1||Ouabain；DOCAsalt rat；Hypertension.:1||Oxidative damage:1||P2Y12 receptor gene polymorphism:1||PROGENITOR CELLS:1||PWW:1||Papillary muscles:1||Patent ductus arteriosus:1||Percutaneous coronary artery intervention:1||Percutaneous coronary interventions:1||Pericardial effusion:1||Platelet inhibitors:1||Pleural effusion:1||Pluripotent embryonic stem cell markers:1||Poly2hydroxyethyl methaciylate:1||Postoperative complications:1||Predictors:1||Prehypertension:1||Propafenone.:1||Proteinuria:1||Pulmonary embolism:1||Pulmonary trunk:1||Pulmonary vein:1||Q3 fatty acid:1||RETINOIC ACID:1||Regeneration:1||Regulatory T cell:1||Relationship between InStent Restenosis and Persistent Inflammation in Patients with Acute Coronary Syndrome:1||Remodeling:1||Remodelling:1||Renal endpoint:1||Restenosis:1||Revascularization:1||Rheumatoid arthritis:1||Rhoassociated protein kinase:1||Rotation:1||SAMS:1||SDF1 alpha:1||SELFRENEWAL:1||STsegmentelevation myocardial infarction:1||Sca1+cardiac stem cell:1||Serum:1||Sinus of Valsalva:1||Sirolimus:1||Smooth muscle progenitor cell:1||Sphere:1||Statin side effect:1||Statins:1||Stenosis:1||Stent Deformation:1||Strains:1||TIMP2:1||TUMORSUPPRESSOR:1||Takayasu arteritis:1||Talin:1||Target goal achievement:1||Thrombosis:1||Thymosin beta 4:1||Ticagrelor:1||Transcatheter aortic valve replacement:1||Trimetazidine:1||Twist:1||Uric acid:1||Variant angina:1||Vascular endothelial growth factor receptor:1||Vascular injury:1||Vascular smooth muscle cell:1||Vascularization:1||Women:1||Zotarolimus:1||acetylcholine:1||adipose stem cell:1||adiposederived stem cell:1||adiposederived stromal cells:1||ambulatory:1||angina:1||angiogenesis:1||angiopoietin2:1||antiangiogenesis:1||antiplatelet drug:1||antiplatelet theraphy&nbsp:1||aortic pressure:1||aspirin:1||augmentation index:1||baPWV:1||balloon angioplasty:1||blood pressure control:1||blood pressure monitoring:1||cardiac:1||cardiac imaging techniques:1||cardiac remodeling:1||cardiac stem cells:1||cardiogenic:1||cardiomyocyte survival:1||cardiovascular diseases:1||carotid intimamedia thickness:1||carotid strain:1||catheter ablation:1||cholesterol:1||chronic kidney disease:1||cilostazol:1||clinical research:1||clinical trials:1||clopidogrel:1||clopidogrel bisulfate:1||clopidogrel resinate:1||combination treatment:1||combination drug therapy:1||complication:1||coronary artery:1||coronary artery aneurysm:1||coronary artery stenosis:1||coronary bifurcation angioplasty:1||coronary bifurcation lesions:1||coronary bifurcation stenting:1||coronary disease:1||coronary intervention:1||coronary pseudoaneurysm:1||covered stent:1||critical limb ischemia:1||curvature:1||cytochrome P450 CYP2C19:1||cytokines:1||deferred stenting:1||diabetic patients:1||differentiation:1||doortocath eter time:1||dual antiplatelet therapy:1||dualantiplatelet therapy:1||duration of therapy:1||echocardiography:1||efficacy:1||electrocardiogram:1||endothelial function:1||endothelial progenitor cells:1||engraftment:1||extracorporeal membrane oxygenation:1||focal adhesion:1||graft survival:1||heart volume:1||hospital mortality:1||hydroxymethylglutarylCoA reductase inhibitors:1||hypoxia:1||immortalization:1||in vitro angiogenesis:1||indothiazinone:1||infarct size microvascular obstruction:1||integrin:1||integrin IIb3:1||integrin activation:1||intensive care unit:1||intracoronary delivery:1||intracoronary imaging:1||intramyocardial injection:1||intravenous injection:1||invasive coronary angiography:1||left:1||left main coronary artery (LMCA) disease:1||left ventricular:1||lipid:1||lipid bilayer:1||lipid core burden index:1||major adverse cerebrocardiovascular events:1||mechanical force:1||mechanosensor:1||mechanotransduction:1||membrane protein:1||microcirculatory resistance:1||minimally invasive direct coronary artery bypass:1||mortality:1||myocardial ischemia:1||myocardial perfusion:1||nearinfrared spectroscopy:1||nebivolol:1||obesity:1||old age:1||omega3 fatty acids:1||optical coherence tomography:1||optical coherent tomography:1||percutaneous coronary intervention (complex PCI):1||peripheral arterial disease:1||peripheral artery disease:1||physiological indexes:1||physiology:1||pioglitazone:1||pitavastatin:1||platelet:1||pleiotropic effect:1||pluripotent stem cells:1||polytetrafluoroethylene:1||porous mesh structure:1||prasugrel:1||predictor:1||prehospital delay:1||pulse pressure:1||pulse wave velocity:1||randomized controlled trial:1||recurrence:1||red ginseng extract:1||refractoriness:1||regenerative medicine:1||registries:1||restitution:1||retrograde coronary venous delivery:1||revascularization:1||rosuvastatin calcium:1||secondary prevention:1||secretome:1||sepsis:1||sepsisinduced myocardial dysfunction:1||shock:1||singlepill combination:1||smoking:1||smoothness index:1||spatial dispersion:1||stable:1||statin:1||stem cell:1||stent implantation:1||stent strategy:1||stents:1||strain rate imaging:1||stressinduced cardiomyopathy:1||survival analysis:1||swine model:1||symptom onset:1||symptomtodoor time:1||talin modulator:1||thiazides:1||thrombolysis in myocardial infarction:1||ticagrelor:1||tissue Doppler:1||tissue engineering:1||tolerability:1||tomography, optical coherence:1||transmembrane domain:1||trauma:1||treatment outcome:1||triglycerides:1||triple antiplatelet therapy:1||triple antithrombotic therapy:1||troughpeak ratio:1||ultrasonography, interventional:1||valsartan:1||variant angina:1||vascular growth:1||ventricular arrhythmia:1||ventricular dysfunction:1||ventricular function:1||ventricular septum:1||viability:1||warfarin:1||zotarolimuseluting stent:1||고혈압·:1||고혈압·경동맥 내막중막 두께·좌심실비대.:1||관상동맥:1||관상동맥 스텐트:1||대동맥판막:1||동맥경화증；Bcl2 유전자.:1||동맥관개존증:1||동정맥기형:1||동정맥루:1||이형협심증:1||재협착:1||좌전하행지 관상동맥에서 좌심실로 유출되는 관동정맥루 1예:1||한국인의 관동맥질환에 띠른 혈중 지질 및 위험인자의 비교연구:1||.:1||혈압；맥압；좌심실비대；관동맥질환.:1||1stent:1||2stent:1||2stenting technique:1||24h blood pressure:1||3D bioprinting:1||ACS:1||ACTIVATING TRANSCRIPTION FACTOR3:1||ADSC sheet:1||Absorbable implants:1||Adipose:1||Adipose stem cell:1||Adipose tissue:1||Adiposederived stem cells:1||Adjunctive pharmacotherapy:1||Adult peripheral blood:1||Angiogenic cell:1||Angiotensin:1||Anomalous origin of left coronary artery from artery；Coronary vessel anomalies；Collateral circulation.:1||Anomalous origin of left main coronary artery:1||Antiserum aggregation:1||Aorta:1||Apical ballooning syndrome:1||Arterial stiffness:1||Ascorbic acid:1||Asian:1||Aspirin:1||Atherosclerosis；Bcl2 genes:1||Baseline drift correction:1||Bifurcation lesion:1||Bioresorbable vascular scaffold:1||Black raspberry:1||Bleeding:1||Blood pressure:1||Blood pressure；Pulse pressure；Left ventricular hypertrophy；Coronary artery disease.:1||Bronchial artery fistula:1||CXCR4:1||Cardiac sphere:1||Cardioprotection:1||Cardiovascular disease:1||Carotid intima media thickness:1||Carotid intimamedia thickness:1||Carotid intimamedia thickness·Hypertension·Left ventricular hypertrophy.:1||Catechin:1||Catheter ablation:1||Cell differentiation:1||Central blood pressure:1||Cholesterol:1||Chronic coronary total occlusion:1||Chronic total occlusion:1||Cilostazol:1||Circulating stem cells:1||Clinical sample pretreatment:1||Clodronate:1||Complex lesion:1||Complications:1||Congenital coronary artery:1||Continuous immunosensor:1||Coronary Angiography:1||Coronary arteriovenous malformation:1||Coronary artery calcium:1||Coronary artery fistula:1||Coronary circulation:1||Coronary flow reserve:1||Coronary intervention:1||Coronary stenosis:1||Cytokines:1||DOCAsalt rat:1||Diabetes:1||Diabetic nephropathy:1||Diabetic patients:1||Dilated cardiomyopathy:1||Dobutamine stress echocardiography:1||Drug coated balloon:1||Dyslipidemia:1||Dyslipidemias:1||ES CELLS:1||Echocardiography.:1||Elderly:1||Electric countershock:1||Electrical cardioversion:1||Embryonal carcinoma stem cells:1||Endothelial Differentiation:1||Endothelial function:1||Endothelialcolony forming cell:1||Endovascular procedures:1||Everolimus:1||Exercisestress electrocardiography:1||Extracellular matrix:1||Fibroblast growth factor 2:1||Fimasartan:1||Flexiblestarting dose:1||GENEEXPRESSION MEASUREMENTS:1||GelMAcollagen hydrogel:1||Gradient nanopattern plates:1||Granulocytecolony stimulating factor·Bone marrow mononuclear cell·Cardiac remodeling·
Myocardial infarction·Reperfusion:1||Guidewire entrapment:1||HUMAN BLASTOCYSTS:1||Highdensity lipoprotein cholesterol:1||

STATISTICS: Total View :12,785,663; Today View :17,470

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE